Andrea Calcagno
机构: Unit of Infectious Diseases, Department of Medical Sciences, University of Torino
每年引用次数
引用次数
引用: 5,344
H-指数: 35
I10-指数 : 151
出版物: 444
Blood brain barrier impairment is associated with cerebrospinal fluid markers of neuronal damage in HIV-positive patients
A. Calcagno , C. Atzori , A. Romito , D. Vai
Journal of NeuroVirology 22 ( 1) 88 -92
26
2016
Peripheral and cerebrospinal fluid immune activation and inflammation in chronically HIV-infected patients before and after virally suppressive combination antiretroviral therapy (cART).
E. Merlini , F. Iannuzzi , A. Calcagno , F. Bai
Journal of NeuroVirology 24 ( 6) 679 -694
1
2018
Elimination Half-Life May Explain the Relative Efficacy of Boceprevir and Telaprevir in the Treatment of Hepatitis C Virus Genotype 1
A. Calcagno , L. Boglione , F. G. De Rosa , G. Di Perri
Clinical Infectious Diseases 56 ( 11) 1677 -1678
1
2013
Healthcare-Associated Klebsiella pneumoniae carbapenemase Producing K. pneumoniae Bloodstream Infection: The Time Has Come
S. Corcione , C. S. Cardellino , A. Calcagno , L. Fossati
Clinical Infectious Diseases 59 ( 2) 321 -322
8
2014
The chitinases expression is related to Simian Immunodeficiency Virus Encephalitis (SIVE) and in HIV encephalitis (HIVE).
C. Sanfilippo , G. Nunnari , A. Calcagno , L. Malaguarnera
Virus Research 227 220 -230
12
2017
Short-term additional enfuvirtide therapy is associated with a greater immunological recovery in HIV very late presenters: a controlled pilot study
S. Bonora , A. Calcagno , C. Cometto , S. Fontana
Infection 40 ( 1) 69 -75
5
2012
Ageing with HIV: a multidisciplinary review
A. Calcagno , S. Nozza , C. Muss , B. M. Celesia
Infection 43 ( 5) 509 -522
16
2015
Erratum to: Ageing with HIV: a multidisciplinary review.
A. Calcagno , S. Nozza , C. Mussi , B. M. Celesia
Infection 43 ( 5) 627 -627
2015
O4 Early start of antiretroviral therapy (ART) during primary HIV infection (PHI) is associated with faster optimal immunological recovery: results of Italian Network of ACuTe HIV InfectiON (INACTION) retrospective study
A. Muscatello , A. Bandera , M. Fabbiani , I. De Benedetto
Journal of virus eradication 3 1 -2
1
2017
Cerebrospinal fluid abacavir concentrations in HIV-positive patients following once-daily administration.
A. Calcagno , C. Pinnetti , A. De Nicolò , E. Scarvaglieri
British Journal of Clinical Pharmacology 84 ( 6) 1380 -1383
1
2018
Treating HIV Infection in the Central Nervous System
A. Calcagno , G. Di Perri , S. Bonora
Drugs 77 ( 2) 145 -157
6
2017
Tenofovir Plasma Concentrations According to Companion Drugs: a Cross-Sectional Study of HIV-Positive Patients with Normal Renal Function
A. Calcagno , D. Gonzalez de Requena , M. Simiele , A. D'Avolio
Antimicrobial Agents and Chemotherapy 57 ( 4) 1840 -1843
31
2013
Efficacy, Tolerability and Virological Consequences of Long-Term Use of Unboosted Atazanavir Plus 2 NRTIs in HIV-Infected Patients
S. Bonora , A. Calcagno , O. Vigano , P. Bigliano
Current HIV Research 12 ( 5) 339 -346
7
2014
Incidence and clinical features of stroke in HIV patients in HAART era: a meta-analysis
Giorgio Quadri , Fabrizio D'Ascenzo , E Cerrato , P Omede'
European Heart Journal 34 64 -64
2013
Cardiac dysfunction in pauci symptomatic human immunodeficiency virus patients: a meta-analysis in the highly active antiretroviral therapy era
Enrico Cerrato , Fabrizio D'Ascenzo , Giuseppe Biondi-Zoccai , Andrea Calcagno
European Heart Journal 34 ( 19) 1432 -1436
86
2013
Natural History of HIV Infection and Evolution of Antiretroviral Therapy
G. Di Perri , S. Audagnotto , F. Gobbi , L. Trentini
Cardiovascular Disease in AIDS 1 -13
2009
Seminal pharmacokinetics and antiviral efficacy of once-daily maraviroc plus lopinavir/ritonavir in HIV-infected patients.
A. Calcagno , S. Nozza , M. Simiele , M. G. Milia
Journal of Antimicrobial Chemotherapy 69 ( 9) 2586 -2588
1
2014
Intracellular accumulation of atazanavir/ritonavir according to plasma concentrations and OATP1B1, ABCB1 and PXR genetic polymorphisms
A. D'Avolio , C. Carcieri , J. Cusato , M. Simiele
Journal of Antimicrobial Chemotherapy 69 ( 11) 3061 -3066
32
2014
Effect of SNPs in human ABCB1 on daptomycin pharmacokinetics in Caucasian patients
L. Baietto , A. D'Avolio , J. Cusato , S. Pace
Journal of Antimicrobial Chemotherapy 70 ( 1) 307 -308
8
2015
Raltegravir: is a 400 mg once-daily dose enough?
M. Lanzafame , A. Hill , E. Lattuada , A. Calcagno
Journal of Antimicrobial Chemotherapy 65 ( 3) 595 -597
5
2010